Are you Dr. Reinhardt?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 59 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
125 Paterson St
Clinical Academic Building Suite 5100a
New Brunswick, NJ 08901Phone+1 732-235-7219Fax+1 732-212-0713
Summary
- Dr. Rickey Reinhardt, MD is an endocrinologist in New Brunswick, New Jersey. He is currently licensed to practice medicine in New Jersey, Maryland, and Louisiana. He is affiliated with Robert Wood Johnson University Hospital.
Education & Training
National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1991 - 1994
George Washington UniversityResidency, Internal Medicine, 1989 - 1991
Louisiana State University School of Medicine in New OrleansClass of 1989
Certifications & Licensure
NJ State Medical License 1997 - 2025
MD State Medical License 1990 - 1997
LA State Medical License 1989 - 1989
Clinical Trials
- Safety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD Trial Start of enrollment: 2017 Mar 29
Publications & Presentations
PubMed
- 1 citationsSafety and biodistribution of XC001 (encoberminogene rezmadenovec) gene therapy in rats: a potential therapy for cardiovascular diseases.Duncan J Stewart, Albert Gianchetti, Dawn Byrnes, Howard C Dittrich, Barb Thorne
Gene Therapy. 2024-01-01 - 43 citationsGene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term SafetyMaria Pia Cicalese, Francesca Ferrua, Laura Castagnaro, Katie Rolfe, Erika H. De Boever
Molecular Therapy. 2018-03-07 - 1 citationsAlbiglutide efficacy and safety in the Latino/Hispanic subpopulation for the integrated phase III programJaime A. Davidson, Angela Jones-Leone, Timothy Wilson, Antonio Nino, Sergio Forero-Schwanhaeuser
Postgraduate Medicine. 2017-10-30
Press Mentions
XyloCor Therapeutics : Names Rickey Reinhardt, MD, PhD, Chief Medical OfficerAugust 7th, 2019
